Bo Jin

Effect of the cholesteryl ester transfer protein inhibitor, anacetrapib, on lipoproteins in patients with dyslipidaemia and on 24-h ambulatory blood pressure in healthy individuals: two double-blind, randomised placebo-controlled phase I studies

Rajesh Krishna, Matt S. Anderson, Arthur Bergman et al. · The Lancet · 2007 · 277 citations

Life Sciences, Pharmacology, Pharmacotherapy +15

Effect of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes, on the Pharmacokinetics of Raltegravir

Larissa Wenning, William D. Hanley, Diana M. Brainard et al. · Antimicrobial Agents and Chemotherapy · 2009 · 160 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies

S. Aubrey Stoch, Stefan Zajic, Julie A. Stone et al. · Clinical Pharmacology & Therapeutics · 2009 · 156 citations

Medicine, Pharmacology, Pharmacotherapy +17

Tolerability of Fosaprepitant and Bioequivalency to Aprepitant in Healthy Subjects

Kenneth C. Lasseter, Jay J. Gambale, Bo Jin et al. · The Journal of Clinical Pharmacology · 2007 · 133 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells

Li Ping Zhang, Terumi Takahara, Yutaka Yata et al. · Journal of Hepatology · 1999 · 122 citations

Life Sciences, Molecular Biology, Gene Expression +16